Expression of Wnt target genes in solid pseudopapillary tumor of the pancreas: A pilot study

Pancreas

Volumn 38, Issue 2, 2009, Pages

  Kang, Chang Moo ^a,b   Kim, Hyun Ki ^a   Kim, Hoguen ^a   Choi, Gi Hong ^a,b   Kim, Kyung Sik ^a,b   Choi, Jin Sub ^a,b   Lee, Woo Jung ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Immunohistochemistry; Pancreas; Solid pseudopapillary tumor; Wnt

Indexed keywords

BETA CATENIN; CYCLIN D1; KI 67 ANTIGEN; MATRILYSIN; WNT PROTEIN; CCND1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; MMP7 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE C MYC; PANCREAS; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOLID PSEUDOPAPILLARY TUMOR; TUMOR VOLUME; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; ONCOGENE MYC; PAPILLARY CARCINOMA; PATHOLOGY; PHYSIOLOGY; PILOT STUDY;

ADOLESCENT; ADULT; BETA CATENIN; CARCINOMA, PAPILLARY; CYCLIN D1; FEMALE; GENE EXPRESSION; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; PANCREATIC NEOPLASMS; PILOT PROJECTS; WNT PROTEINS;

EID: 65349086792     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318196d198     Document Type: Article

References (47)

1. Canzonieri V, Berretta M, Buonadonna A, et al. Solid pseudopapillary tumour of the pancreas. Lancet Oncol. 2003;4(4):255-256.
2. Crawford BE 2nd. Solid and papillary epithelial neoplasm of the pancreas, diagnosis by cytology. South Med J. 1998;91(10):973-977.
3. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol. 2000;17(1):66-80.
4. Panieri E, Krige JE, Bornman PC, et al. Operative management of papillary cystic neoplasms of the pancreas. J Am Coll Surg. 1998; 186(3):319-324.
5. Martin RC, Klimstra DS, Brennan MF, et al. Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol. 2002; 9(1):35-40.
6. Kloppel G, Solcia E, Longnecker DS, et al. Histological Typing of Tumors of the Exocrine Pancreas. New York, NY: Springer; 1996.
7. Kang CM, Kim KS, Choi JS, et al. Solid pseudopapillary tumor of the pancreas suggesting malignant potential. Pancreas. 2006;32(3): 276-280.
8. Lee WJ, Park YT, Choi JS, et al. Solid and papillary neoplasms of the pancreas. Yonsei Med J. 1996;37(2):131-141.
9. Sun CD, Lee WJ, Choi JS, et al. Solid-pseudopapillary tumours of the pancreas: 14 years experience. ANZ J Surg. 2005;75(8):684-689.
10. Salvia R, Bassi C, Festa L, et al. Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. J Surg Oncol. 2007;95(4):304-310.
11. Lieber MR, Lack EE, Roberts JR, et al. Solid and papillary epithelial neoplasm of the pancreas. An ultrastructural and immunocytochemical study of six cases. Am J Surg Pathol. 1987;11(2):85-93.
12. Kallichanda N, Tsai S, Stabile BE, et al. Histogenesis of solid pseudopapillary tumor of the pancreas: the case for the centroacinar cell of origin. Exp Mol Pathol. 2006;81(2):101-107.
13. Schlosnagle DC, Campbell WG Jr. The papillary and solid neoplasm of the pancreas: a report of two cases with electron microscopy, one containing neurosecretory granules. Cancer. 1981;47(11):2603-2610.
14. Yagihashi S, Sato I, Kaimori M, et al. Papillary and cystic tumor of the pancreas. Two cases indistinguishable from islet cell tumor. Cancer. 1988;61(6):1241-1247.
15. Matsunou H, Konishi F. Papillary-cystic neoplasm of the pancreas. A clinicopathologic study concerning the tumor aging and malignancy of nine cases. Cancer. 1990;65(2):283-291.
16. Miettinen M, Partanen S, Fraki O, et al. Papillary cystic tumor of the pancreas. An analysis of cellular differentiation by electron microscopy and immunohistochemistry. Am J Surg Pathol. 1987;11(11):855-865.
17. Chen C, Jing W, Gulati P, et al. Melanocytic differentiation in a solid pseudopapillary tumor of the pancreas. J Gastroenterol. 2004; 39(6):579-583.
18. Geers C, Moulin P, Gigot JF, et al. Solid and pseudopapillary tumor of the pancreas - review and new insights into pathogenesis. Am J Surg Pathol. 2006;30(10):1243-1249.
19. Tang LH, Aydin H, Brennan MF, et al. Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol. 2005;29(4):512-519.
20. Nishihara K, Nagoshi M, Tsuneyoshi M, et al. Papillary cystic tumors of the pancreas. Assessment of their malignant potential. Cancer. 1993;71(1):82-92.
21. Sclafani LM, Reuter VE, Coit DG, et al. The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer. 1991; 68(1):153-158.
22. Zinner MJ, Shurbaji MS, Cameron JL. Solid and papillary epithelial neoplasms of the pancreas. Surgery. 1990;108(3):475-480.
23. Hibi T, Ojima H, Sakamoto Y, et al. A solid pseudopapillary tumor arising from the greater omentum followed by multiple metastases with increasing malignant potential. J Gastroenterol. 2006;41(3): 276-281.
24. Takahashi Y, Hiraoka N, Onozato K, et al. Solid-pseudopapillary neoplasms of the pancreas in men and women: do they differ? Virchows Arch. 2006;448(5):561-569.
25. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160(4):1361-1369.
26. Tanaka Y, Kato K, Notohara K, et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid- pseudopapillary neoplasm. Cancer Res. 2001;61(23):8401-8404.
27. Jawhari AU, Farthing MJ, Pignatelli M. The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation. J Pathol. 1999;187(2):155-157.
28. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000;87(8): 992-1005.
29. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14(15): 1837-1851.
30. Satoh S, Daigo Y, Furukawa Y, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet. 2000;24(3):245-250.
31. Munemitsu S, Albert I, Souza B, et al. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A. 1995;92(7): 3046-3050.
32. Crawford HC, Fingleton BM, Rudolph-Owen LA, et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 1999;18(18):2883-2891.
33. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999;96(10):5522-5527.
34. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509-1512.
35. Saeki H, Tanaka S, Sugimachi K, et al. Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer. Dig Dis Sci. 2002;47(12):2738-2742.
36. Li YJ, Wei ZM, Meng YX, et al. beta-Catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol. 2005;11(14):2117-2123.
37. Prange W, Breuhahn K, Fischer F, et al. beta-Catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol. 2003;201(2):250-259.
38. Leinonen T, Pirinen R, Bohm J, et al. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis. Lung Cancer. 2006;51(3):313321.
39. Sillanpaa SM, Anttila MA, Voutilainen KA, et al. Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression. Int J Cancer. 2006;119(8): 1792-1799.
40. Min Kim S, Sun CD, Park KC, et al. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas. J Surg Oncol. 2006;94(5):418-425.
41. Tiemann K, Heitling U, Kosmahl M, et al. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q. Mod Pathol. 2007.
42. Muller-Hocker J, Zietz CH, Sendelhofert A. Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas. Mod Pathol. 2001;14(2):47-53.
43. Fernandez-Figueras MT, Puig L, Musulen E, et al. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol. 2007;20(1):90-101.
44. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004;16(5):558-564.
45. Polette M, Nawrocki-Raby B, Gilles C, et al. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol. 2004;49(3):179-186.
46. Adair CF, Wenig WB, Heffess CS. Solid and pseudopapillary cystic carcinoma of the pancreas: a tumor of low grade malignant potential. Int J Surg Pathol. 1995;2:326.
47. Lai HW, Su CH, Li AF, et al. Malignant solid and pseudopapillary tumor of the pancreas - clinicohistological, immunohistochemical, and flow cytometric evaluation. Hepatogastroenterology. 2006;53(68):291-295.